Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

Market advancements are driven by rising incidences of neuroendocrine tumors, improved diagnostics, and targeted therapies. Key players like Novartis AG and Pfizer Inc. are investing in innovative ...

Around 9,000 people are diagnosed with this kind of cancer every year in the UK, so Brits are being urged to look out for the ...

A father of four who sadly passed away from a rare form of cancer inspired a foundation that hopes to give back.

In particular, T-cell engager bsAbs facilitate immune cell–mediated tumor destruction by linking T cells to tumor antigens. Instead, dual immune checkpoint inhibitors (CPIs) enhance immune activation ...

MIAMI, FLORIDA (April 9, 2025) – A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of ...

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

Sidney Raz, known for his popular 'Life Hacks' series, learned he had stomach cancer despite having no symptoms Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

The approval was based on the results of the phase 3 CABINET study, which compared cabozantinib to a placebo in patients with advanced pancreatic neuroendocrine tumors and advanced extrapancreatic ...

The approval for use in advanced neuroendocrine tumors is supported by data from the phase 3 CABINET trial (ClinicalTrials.gov Identifier: NCT03375320). The double-blind, placebo-controlled study ...

Woese Institute for Genomic Biology, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States Pancreatic neuroendocrine tumors (PNETs) are rare tumors that are often diagnosed ...